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Condensation of substituted aromatic ketones (acetoph none) and substituted aldehydes give 
unsaturated ketones 14 (chalcones) which react with o-phenylenediamine 7 to afford the corresponding 
benzodiazepines 15. Treatments of benzodiazepines under basic conditis give benzimidazole derivatives. 
Structures of all synthesized compounds have been chara terized by their NMR and mass spectral data. 
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The antihelmintic drugs derived from 
benzimidazole are the largest chemical family 
used to treat endoparasitic diseases in 
domestic animals and humans, characterized 
by their high therapeutical index in the 
different helmintosis, polyvalent effect, and 
low toxicity. Specifically, it has been 
estimated that 10 million people worldwide 
could be infected, and in the past 10 years an 
increase of the infection has been reported 
among domestic animals (pigs, horses), and 
wildlife, with a consequent increase among 
humans. 
In recent years, much attention has 
been given to the substituents at the 1- and 2- 
position of the benzimidazole ring which gave 
good antiviral activities. Many reports have 
revealed that the influence of the substitution 
at the 1,2 and 5-positions of the 
benzimidazole ring was very important for 
their pharmacological effects (Ashnagar et al., 
2009; Patel and Singh, 2009). It is well known 
that several 1,2-disubstituted benzimidazoles 
1 (DeLong, 1984; Miller et al., 1985), 2 
(Porcari et al., 1998), 3 (Victor et al., 1997), 4 
(Garuti et al., 1998), 5 (Swayze et al., 1993), 6 
(Gardiner et al., 1995) were potent inhibitors 
of RNA viruses. Thus, this let us to prepare 
and evaluate other derivatives (Figure 1). 
Benzimidazole derivatives have been 
intensively used as drugs in medicinal 
chemistry such as antihelmentic (Hazelton et 
al., 1995), antihistaminic (Al-Muhaimeed, 
1997) and antiulcerative (Richter, 1997), 
Facing the resistance phenomena, the 
development of new molecules that inhibited 
resistant strains revived interest in the search 
for novel bioactive compounds. Therefore we 
decided to develop novel structural analogs of 
benzimidazole. We expanded our research in 
the substitution at the 2-position. The choice 













































of chains linked at the C-2 was made in view 
of their presence in other classes of antiviral 
compounds. In this paper, we describe the 
synthesis of benzimidazole. As strategy 
approach, we used 1,5-benzodiazepines as 
intermediaries which were converted to 
benzimidazole under basic conditions. 
 
MATERIALS AND METHODS 
General 
Melting points were determined with a 
Kofler hot-stage apparatus and are 
uncorrected. 1H NMR and 13C NMR were 
recorded on a Bruker Avance 300 MHz 
spectrometer instrument using TMS as an 
internal standard. Mass spectrometric 
measurements were performed using 
HP5989X instrument. Column 
chromatography was carried out over silica 
gel 60 (0.04-0.06 mm) (Merck AG Darmstadt, 
Germany). All spectrometers analysis were 
realized at laboratory CEISAM of Nantes 
University.  
 
General method to synthesis of 
benzodiazepine 
To a solution of chalcone 14 (35 
mmol) in ethanol (30 mL), a few drops of 
triethylamine and o-phenylenediamine (un or 
substituted) (42 mmol) were added. The 
mixture was heated under reflux for 10 hours 
in the dark. The mixture was cooled at room 
temperature and then put in the freezer 
overnight. The solid product 15 was 
separated, filtered, and washed with cold 
ethanol. The residue was purified by column 
chromatography on silica gel. 
4-diphenyl-2,3-dihydro-1,5-benzodiazepine 
15a 
From 1,3-diphenylpropenone 14a 
(7.29 g, 35 mmol) and o-phenylenediamine 7a 
(4.54 g, 42 mmol) was obtained 15a (5.32 g; 
51%) as yellow crystals; Rf : 0.4 
(hexane/dichloromethane v/v: 70/30); mp: 
155-156 °C. 
1H NMR (CDCl3, 300 MHz) δ: 3.05-
3.08 (m, 2H, CH2); 5.22 (d, 1H, NH); 5.87-
5.88 (m, 1H, H2); 6.80-7.80 (m, 14H, aromatic 
protons). 
13C NMR (CDCl3, 75 MHz) δ: 37.7 
(C3); 64.4 (C2); 118.3 (C9); 121.7 (C7); 125.3 
(C6);128.6 (C17, C21); 131.1 (C8); 131.9 (C18, 
C20); 132.2 (C19); 132.3 (C12, C14); 133.1 (C11, 
C15); 133.8 (C13); 135.5 (C10); 138.8 (C5a); 
143.5 (C16); 146.6 (C9a); 165.8 (C4). 
Mass (m/z) = M+ = 298 (26); m/z (%) 
= 221.25 (25); 194.20 (100); 91(21.26); 77 
(20.25); 63 (12.25). 
 






methoxyphenyl)propenone 14b (8.90 g, 35 
mmol) and o-phenylenediamine 7a (4.54 g, 42 
mmol) was obtained 15b (6.74 g; 56%) as 
yellow crystals; Rf : 0.5 (hexane/ethyl acetate 
v/v : 80/20); mp: 140-141 °C. 
1H NMR (CDCl3, 300 MHz) δ: 3.04 
(dd, 1H, H3α, J = 9 Hz, and 15 Hz), 3.32 (dd, 
1H, H3β, J = 6 Hz, and 15 Hz), 3.83 (s, 4H, 
OCH3 et NH), 5.15 (dd, 1H, H2, J = 6 Hz and 
9 Hz); 6.76-7.37 (m, 12H, aromatic protons); 
15.30 (s, 1H, OH). 13C NMR (CDCl3, 75 
MHz) δ: 36.7 (CH3); 55.4 (C2); 69.3 (C3); 
114.3 (C18, C20); 114.8 (C9); 116.2 (C12); 
120.4 (C7); 120.8 (C10); 124.2 (C14); 
127.1(C6); 132.7 (C17, C21); 133.6 (C8); 135.7 
(C15); 136.5 (C13); 136.8 (C16); 137.1 
(C5a);145.0 (C9a) ; 150.5 (C19); 162.0 (C11) ; 
171.2 (C4). Mass (m/z) = 344. M
+ = 344; m/z 
(%); M+ 2 = 346 (16.41); M+1 = 345 (72.32); 
240 (100); 119 (32.96); 91 (35.85) 77 (11.40). 
Thienyl-4-tolyl-2,3-dihydro-1,5-
benzodiazepine 15c 
From 1-tolyl-3-thienyl propenone 14c 
(7.99 g, 35 mmol) and o-phenylenediamine 7a 
(4.54 g, 42 mmol) was obtained 15c (5.01 g; 
45%) as yellow crystals; Rf: 0.4 (hexane/ethyl 
acetate v/v: 80/20); mp: 125-126 °C.  
1H NMR (CDCl3, 300 MHz) δ: 2.38 (s, 
1H, CH3); 2,99 (dd, 1H, HA, 
3JAX = 9 Hz, 
2JAM 
= 13.2 Hz); 3.26 (dd, 1H, HM, 
3JBX = 4.2 Hz, 
2JAM = 13.2 Hz); 3,72 (m, 1H, NH); 5.50 (dd, 
1H, HX, 
3JAX = 9 Hz, 
2JMX = 4.2 Hz); 6.78- 
7.78 (m, 11H, aromatic and thienyl protons). 
13C NMR (CDCl3, 75 MHz) δ: 21.4 
(CH3); 37.7 (C3); 66.8 (C2); 121.5 (C9); 125.4 
(C7); 128.7 (C6); 128.9 (C18); 132.1 (C20); 
133.4 (C16); 134.0 (C8); 134.9 (C19); 135.2 
(C11, C15); 136.2 (C12, C14); 138.2 (C10); 140.5 
(C5a); 142.6 (C13); 148.4 (C9a); 167.2 (C4). 
Mass (m/z) = 318. M+ = 318 (10); m/z (%); 
319 (5); 208 (100); 110 (20.15); 91 (21.26); 
77 (11.91); 63 (12.25); 39 (25,1). 
Phenyl-2-Thienyl-2,3-dihydro-1,5-
benzodiazepine 15d 
From 1-phenyl-3-thienyl propenone 
14d (7.50 g, 35 mmol) and o-
phenylenediamine 7a (4.54 g, 42 mmol) was 
obtained 15d (5.53 g; 52%) as blackish 
crystals; Rf : 0.4 (hexane/ethyl acetate v/v: 
95/5); mp: 120-121 °C.  
1H NMR (CDCl3, 300 MHz), δ: 3.06 
(dd, 1H, HA, 
3JAX = 9 Hz, 
2JAM = 12 Hz); 3.32 
(dd, 1H, HM, 
3JMX = 6 Hz, 
2JAM = 12 Hz); 3.79 
(s, 1H, NH): 5.55 (dd, 1H, HX, 
3JAX = 9 Hz, 
2JMX = 6 Hz); 6.83 – 7.92 (m, 12H, aromatic 
and thienyl protons). 
13C NMR (CDCl3, 75 MHz) δ: 37.9 
(C3); 66.7 (C2); 121.5 (C9); 124.2 (C7); 128.7 
(C6); 128.9 (C18); 131.2 (C20); 132.2 (C16); 
134.5 (C8); 134.9 (C19); 136.8 (C11, C15); 
137.2 (C12, C14); 139.2 (C10); 141.5 (C5a); 
142.2 (C13); 148.4 (C9a); 167.2 (C4). Mass 
(m/z) = 304.4. M+ = 304; m/z (%): 306 (5); 





chlorophenyl)propenone 14e (8.49 g, 35 
mmol) and o-phenylenediamine 7a (4.54 g, 42 
mmol) was obtained 15e (8.81 g; 75%) as 
yellow crystals; Rf : 0.5 (hexane/ethyl acetate 
v/v: 90/10); mp: 150-151 °C.  
1H NMR (CDCl3, 300 MHz) δ: 3.12-
3.28 (m, 2H, H3), 3.79 (s, 1H, NH), 5.79-5.83 
(m, 1H, H2), 6.89-7.76 (m, 13H, H aromatic 
protons). 13C NMR (CDCl3, 75 MHz) δ: 36.7 
(CH3); 55.4 (C2); 69.3 (C3); 114.3 (C18, 
C20);114.8 (C9); 116.2 (C12); 120.4 (C7); 120.8 
(C10); 124.2 (C14); 127.1(C6); 132.7 (C17, C21); 
133.6 (C8); 135.7 (C15); 136.5 (C13); 136.8 
(C16); 137.1 (C5a); 145.0 (C9a); 150.5 (C19); 
162.0 (C11); 171.0 (C4). Mass (m/z) = 335. M
+ 
= 335 (35.61); M+1 = 336 (35.61); m/Z (%); 





propenone 14e (8.49 g, 35 mmol) and 4-
methyl-o-phenylenediamine 7b (5.13 g, 42 
mmol) was obtained 15f (7.95 g; 65%) as 
yellow crystals; Rf : 0.7 (hexane/ethyl acetate 
v/v: 90/10); . mp: 122-123 °C.  
1H NMR (CDCl3, 300 MHz); δ: 2.23 
(s, 3H, CH3), 2.99-3.13 (m, 2H, H3), 3.64 (s, 
1H, NH), 5.60-5.63 (m, 1H, H2); 6.56-7.60 
(m, 12H, aromatic protons). 13C NMR 
(CDCl3, 75 MHz) δ: 21.1 (CH3); 34.9 (C3); 
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67.1 (C2); 120.8 (C9); 124.6 (C6); 128.1 
(C7);128.4 (C8, C21); 132.2 (C19); 132.7 (C18); 
134.7 (C20); 136.6 (C12, C14); 138.1 (C11, C15); 
138.6 (C13); 138.8 (C17); 139.2 (C10); 140 
(C5a); 141.2 (C16); 142.1 (C9a); 166,40(C4). 
Mass (m/z) = 346. M+ = 346 (46); M +2 = 348 





nitrophenyl)propenone (10.07 g, 35 mmol) 
and o-phenylene diamine 7a (4.54 g, 42 
mmol) was obtained 15g (8.70 g; 72%) as 
yellow crystal; Rf 0.7 (hexane/ethyl acetate 
v/v: 80/20); mp: 166-167 °C.  
1H NMR (CDCl3, 300 MHz) δ: 3.16 
(d, 2H, H3, J = 6 Hz), 3.71 (s, 1H, NH), 5.74-
5.79 (m, 1H, H2), 6.85-7.88 (m, 12H, aromatic 
protons). 
13C NMR (CDCl3, 75 MHz) δ: 33.3 
(C3); 67.5 (C2); 120.8 (C9); 124.1 (C6); 128.2 
(C7); 128.7 (C19); 129.1 (C21); 132.7 (C8); 
133.2 (C12, C14); 134.2 (C11, C15); 138.2 (C13); 
139.2 (C10); 139.8(C5a); 140.3 (C17); 143.2 
(C16); 143.7 (C9a); 146.7 (C20); 167.1 (C4). 
Mass (m/z) = 377. M+ = 377(29.67); M+2 = 
379 (10.24); M+1 = 378.1 (10.10); m/ z (%) : 





nitrophenyl)propenone (10.07 g, 35 mmol) 
and 4-methyl-o-phenylenediamine 7b (5.13 g, 
42 mmol) was obtained 15h (10.55 g; 77%) as 
yellow crystals; Rf: 0.6 (hexane/ethyl acetate 
v/v: 80/20); mp: 200-201 °C.  
1H NMR (CDCl3, 300 MHz, δ: 2.23 (s, 
3H, CH3); 3.13 (d, 2H, H3, J = 6 Hz); 3.69 (s, 
1H, NH); 5.70-5.67 (m, 1H, H2); 6.85-7.88 
(m, 11H, H aromatic protons). 13C NMR 
(CDCl3, 75 MHz) δ: 20.1 (CH3); 32.1 (C3); 
65.7 (C2); 118.7 (C9); 126.1 (C19); 127.3 (C6); 
129.1 (C21); 129.8 (C7); 129.9 (C8); 131.2 
(C12, C14); 132.6 (C11, C15); 135.2 (C13); 138.2 
(C10); 140.1 (C17); 141.6 (C5a); 143.6 (C9a) ; 
145.2 (C16); 145.6 (C20); 167.1 (C4). 
Mass (m/z) = 391. M+ = 391 (29.74); 
M+2 = 393 (9.15); M+1 = 392 (8.16); m/z 
(%): 208 (100); 207 (48.95); 133 (24.59); 91 
(6.22); 77 (20.69). 
Benzimidazoles 16 - General method 
A solution of 2,3-dihydro-1,5-
benzodiazepine 15 (1 g) and potassium 
carbonate (3 g) in 10 mL of dry 
dimethylformamide (DMF) was refluxed for 
24 h. After cooling to room temperature, 20 
mL of water was added. The organic layer 
was extracted with ethyl acetate (2×50 mL), 
dried with magnesium sulfate, filtered and 
concentrated under reduced pressure. The 
residue was purified by column 
chromatography on silica gel. 
phenyl-1H-benzimidazole 16a  
From 2-(2-chloro-5-nitrophenyl)-4-
phenyl-2,3-dihydroxy-1,5-benzodiazepine 15g 
(1 g, 2.6 mmol) and potassium carbonate (1.8 
g, 13 mmol) was obtained 16a (0.25 g; 50%); 
Rf : 0.5 (hexane/ethyl acetate v/v: 50/50); mp: 
250-251 °C. 
Or from 2,4-diphenyl-2,3-dihydro-1,5-
benzodiazepine 15a (1 g, 3.3 mmol) and 
potassium carbonate (2.28 g, 16.5 mmol) was 
obtained 16a (0.29 g; 45%); Rf : 0.5 
(hexane/ethyl acetate v/v: 50/50); mp: 250-
251 °C Or from 4-Phenyl-2-Thienyl-2,3-
dihydro-1,5-benzodiazepine 15d (1 g, 3.29 
mmol) and potassium carbonate (2.27 g, 16.45 
mmol) was obtained 16a (0.38 g; 60%); Rf : 
0.5 (hexane/ethyl acetate v/v: 50/50); mp: 
250-251 °C.  
1H NMR (CDCl3, 300 MHz); δ: 7.10-
7.92 (m, 15H, aromatic protons); 12.80 (s, 1H, 
NH). 13C NMR (CDCl3, 75 MHz) δ: 111.4 
(C4); 113.1 (C7); 124.3 (C6); 127.7 (C13); 
128.1 (C9);128.8 (C11); 130.1 (C5); 130.9 (C10, 
C12); 131.7 (C8); 138 (C3a); 143.8 (C7a); 151.3 
(C2). Mass (m/z) = 194. M
+ =194 (100); M+1 
= 195 (15.16); m/z (%): 193 (27.21); 102.9 
(11.39); 91 (16.41); 77 (16.75); 51 (10.85). 
phenyl-5-méthyl-1H-benzimidazole 16b  
From 7-methyl-2,4-diphenylbenzo-
diazepine (1 g, 3.2 mmol) and potassium 
carbonate (2.21 g, 16 mmol) was obtained 16b 
(0.27 g; 40%); Rf: 0.2 (hexane/ethyl acetate 
95/5); mp : 220-221 °C. 
Or from 7-methyl-4-phenyl-2-(2-
chlorophenyl) benzodiazepine (1 g, 2.88 
mmol) and potassium carbonate (1.99 g, 14.40 
mmol) was obtained 16b (0.33 g; 55%); Rf: 
0.2 (hexane/ethyl acetate 95/5); mp : 220-221 
°C.  
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1H NMR (CDCl3, 300 MHz) δ: 2.42 (s, 
CH3 ); 7.01–8.17 (m, 8H, aromatic protons); 
12.80 (s, 1H, NH). 13C NMR (CDCl3, 75 
MHz) δ: 21.4 (CH3); 123.6 (C7); 124.5 (C4); 
124.5 (C6); 126.9 (C13); 127.6 (C9);128.8 
(C11); 128.9 (C5); 130.2 (C10, C12); 130.6 (C8); 
130.9 C3a); 150.9 (C7a); 162.3 (C2). Mass 
(m/z): 208 M+ = 208 (29.68); M+1 = 209 
(73.85); M+2 = 210 (12.09); m/z (%) : 191 
(45.78); 189 (100); 145 (45.22); 131 (11); 40 
(30.95). 
2-(paratolyl)-1H-benzimidazole 16c  
From 2-thienyl-4-(p-tolyl) 
benzodiazepine (1 g, 3.14 mmol) and 
potassium carbonate (2.17 g, 15.70 mmol) 
was obtained 16c (0.23 g; 35%); Rf: 0.5 
(hexane/ethyl acetate 25/75);mp: 180-181 °C. 
1H NMR (CDCl3, 300 MHz) δ: 2.45 (s, 
3H, CH3); 6.80–8.15 (m, 8H, aromatic 
protons); 12.80 (s, 1H, NH). 13C NMR 
(CDCl3, 75 MHz) δ: 20.3 (CH3) ; 112.7 (C4, 
C7); 118.6 (C5, C6); 124.2 (C9, C13); 128.5 
(C8); 130.5 (C10, C12); 136.5 (C11); 143.6 (C3a, 
C7a); 154.2 (C2). Mass (m/z): 208 M
+= 208 
(30.25); M+1 = 209 (67.63); M+2 = 210 
(13.20); m/z (%): 191 (40.48); 189 (100); 145 
(45.72); 131 (15.12); 40 (26.35). 
orthohydroxyphenyl-1H-benzimidazole 16d 
From 4-(o-hydroxyphenyl-2-(p-
methoxyphenyl) benzodiazepine (1 g, 2.9 
mmol) and potassium carbonate (1.8 g, 13 
mmol) was obtained 16c (0.21 g; 35%); Rf: 
0.5 (hexane/ethyl acetate 80/20); mp: 198-199 
°C.  
1H NMR (CDCl3, 300 MHz) δ: 6.79 -
7.70 (m, 8H, aromatic protons); 9.80 (s, 1H, 
OH); 12.80 (s, 1H, NH). 13C NMR (CDCl3, 75 
MHz) δ: 115.2 (C4, C7); 118.5 (C10); 120.1 
(C8); 122.6 (C12); 124 (C5, C6) ; 128 (C13); 
132.8 (C11); 138.4 (C3a, C7a); 152.9 (C2); 155.2 
(C9). Mass (m/z): 210 M
+ = 210 (35.21); M+1 
= 211 (70.15); M+2 = 212 (10.40); m/z (%): 
191 (55.66); 189 (100); 145 (40.25); 131 (14); 
40 (28.24). 
 
RESULTS AND DISCUSSION 
For several years, our research team is 
interested in the study of the heteroatomic 
chains of N'-thioacylamidines (Figure 2) and 
the synthesis of benzimidazole derivatives. 
The synthesis of N'-thioacylamidine 
intermediaries are widely established. These 
compounds are easily accessible (Téa et al., 
1986) and are subjected of several physico-
chimique studies (Chehna et al., 1989). 
The obtained results are highlighted as 
follow: dienic (Téa et al., 1983, 1985, 1986a, 
1986b; Chehna et al., 1987), nucleophilic 
(Meslin et al., 1974, 1975) electrophilic 
(Meslin et al., 1974, 1975; Guemas et al., 
1982) and dipolaroplic characters (De Boer et 
al., 1967). 
Theoretical calculations were made 
with the imidinium salts in order to determine 
their reaction ability and stability. The results 
of the theoretical calculations MNDO, AM1 
and PM3 conducted on various imidinium 
salts confirmed their electrophilic character. 
The values of the orbital coefficients 2 Pz and 
the calculated loads using the method AM1 
were indicated in the Figure 3. 
These results showed that carbons C1 
and C3 would be subjected to nucleophilic 
attacks. 
In our search for new benzimidazole 
derivatives, two main synthetic approaches 
were used for the preparation of 
benzimidazole derivatives. In first previous 
works, we used amidinium salts as starting 
material. Recently, we developed in our 
laboratory, a study of the reactivity of 
amidinium salts against binucleophiles like o-
phenylenediamine. Thus, o-phenylenediamine 
7 and amidinium salt 8 were condensed at 5 
°C in ethanol. The reaction afforded 2-phenyl-
1,3-benzimidazole 9 and 2-phenyl-1,3,5-
benzotriazepine 10 (Scheme 1). 
The 2-phenyl-1,3-benzimidazole 9 
resulted from a double attack of o-
phenylenediamine to the C3 of amidinium salt 
and the 2-phenyl-1,3,5-benzotriazepine 10 
from a double attack of o-phenylenediamine 
to the C3 and C1 of amidinium salt. At this 
temperature, the 2-phenyl-1,3-benzimidazole 
9 was formed as the major product which was 
isolated in moderate yield (60%). 
Attempt to conduct the same reaction 
between o-phenylenediamine and 3-thioalkyl 
or 3-thioarylamidinium salt was unsuccessful. 
Surprisingly, Sissouma et al. (2004) obtained 
the 1,3-benzimidazole 11 and the 2-
thiosubstituted benzimidazole 12 (Scheme 2). 
The yield of compounds 11 and 12 
depended on the temperature. By raising the 
temperature, the yield of compound 11 
increased    while     that    of    compound   12 


























decreased. At room temperature, the yield of 
11 became important. We expected to obtain 
the benzotriazepine ring but we did not in 
spite of our numerous attempts. The formation 
of 1,3-benzimidazole could be explained by 
the formation of a seven member ring, 2-
thiosubstituted-1,3,5-benzotriazepine 
intermediate resulting by double attack on C1 
and C3 (Scheme 3). 
The 2-thiosubstituted-1,3,5-
benzotriazepine must evolve by 
intermolecular nucleophilic attack. This 
mechanism was similar to that proposed by 
Ugi et al. (1986) in the synthesis of β-lactams 
(Scheme 3). 
The second original method was based 
on the use of benzodiazepine as intermediate 
compounds. Although many methods for 
synthesizing benzodiazepine ring systems 
they continued to receive a great deal attention 
(Kidwai et al., 2004; Kusanur et al., 2004; 
Kumar and Joshi, 2007; Sanghetti et al., 
2007). 
Generally, benzodiazepines are 
synthesized by the condensation of o-
phenylenediamine with α,β-unsaturated 
carbonyl compounds, haloketones or ketones. 
In the synthesis process, we used chalcone as 
starting material. Thus, chalcones 14 were 
prepared by using Claisen-Schmidt 
condensation with appropriate substituted 
benzaldehydes and substituted aromatic 
ketone (acetophenone) in KOH/EtOH solution 
(Scheme 4). Physical characteristics and 
yields of compounds 14 were summarized in 
Table 1. Indeed, the reaction of binucleophiles 
like o-phenylenediamine with α,β-unsaturated 
carbonyl compounds 14 under reflux in the 
presence of triethylamine in ethanol or 
methanol afforded compounds 15 in moderate 
to good yields (36 - 77%). The reaction was 
carried out in dark in order to exclude any 
influence of light with a possible oxidation of 
o-phenylenediamine (Braulio et al., 1997). 
Benzodiazepine was isolated as only reaction 
product (Scheme 4). 
The yields of the reactions were 
improved by using methanol as solvent 
instead of ethanol. 
The main features of 1H NMR spectra 
in CDCl3 of the isolated compounds 15 are 
reported in Table 2. The 1H NMR analysis of 
compounds 15b, 15c and 15d showed that H3 
protons were not equivalent. In compound 
15b, these protons were appeared as doublet 
dedoublet (dd) at 3.04 and 3.32 ppm; they 
were coupling with H2 proton (5.15 ppm, dd). 
The constants coupling were: 2JH3α- H3β = 15 
Hz, 3JH3α-H2 = 9 Hz and 
3JH3β-H2 = 6 Hz. This 
spectrum is characteristic of AMX system 
which is shown in Figure 4. The yields of 
benzodiazepines, 1H chemical shifts (ppm) 
and 1H-1H coupling constants (J in Hz) of 
compounds 15 in CDCl3 were summarized in 
Table 2.  
The analysis of the AMX system 
corresponding to the protons H2 and H3 gave 
the couplings represented in Figure 4.  To 
confirm the structure of compounds 15, we 
realized the X-ray structure analysis (Bibila et 
al., 2010) of compound 15b which is shown 
on Figure 5 and the crystal data is summarized 
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in Table 3. The molecular of benzodiazepine 
is crystallized in monoclinic system. The ring 
system of benzodiazepine adopted a distorted 
boat conformation. The benzene ring of this 
system formed dihedral angles of 89.69 (12) 
and 48.82 (12) with those of the phenol and 
methoxyphenyl substituent respectively. The 
dihedral angle between the benzene rings was 
49.61 (11). An intramolecular O—H-----N 
hydrogen bond generated an S(6) ring. 
Treatment of compounds 15 with potassium 
carbonate in dimethylformamide (DMF) 
under reflux, afforded 2-substituted 
benzimidazole 16 in moderate yields (40-
60%) and  quinoxaline 17 (Scheme 4). 
The spectroscopic analysis of protons 
showed the disappearance of protons H2 and 
H3 observed in compounds 15. We also noted 
an echo zone concentrated in the aromatic 
area with a decrease of protons. The 
benzimidazolic structures that we proposed 
were confirmed by mass spectrometry data. 
To explain the formation of the benzimidazole 
we proposed the following mechanism: 2,3-
dihydro-benzodiazepine 15 underwent K2CO3 
attacked to give an amidure ion which, by 
intramolecular reaction, reacted on the carbon 
C4 of the imine function. The loss of styrene 
























C1 = 0.491 , q1 = 0.387
C3 = -0.593 , q3 = -0.015
C1 = -0.485 , q1 = 0.388
C3 = 0.590 , q3 = -0.012
C1 = 0.389 , q1 = 0.483
C3 = -0.588 , q3 = -0.012
qi is the charge and Ci the orbital coefficients in the vacant orbital
 















Figure 5: X-ray crystal structure of compound 15b. 
 
 
Table 1: Physical characteristics and yields of compounds 14. 
 
Compounds R2 R3 Yields (%) mp. (°C) 
14a Phenyl Phenyl 71 56-57 
14b p-Methoxyphenyl o-Hydroxyphenyl 85 118-119 
14c Thienyl p-Tolyl 72 81-82 
14d Thienyl Phenyl 78 121-122 
14e o-chlorophenyl Phenyl 70 111-112 
































Table 2: Physical characteristics, 1H chemical shifts (ppm) and 1H-1H coupling constants (J in Hz) of compounds 15 in CDCl3. 
 
Compounds R R2 R3 Yields (%) PF °C δ (ppm) J (Hz) 
15a H Phenyl Phenyl 41  3.06-3.08 (m, H3) 
5.87-5.88 (m, H2) 
 
15b H p-Metoxyphenyl o-Hydroxyphenyl 36 141-142 3.04 (dd, H3α) 
3.32 (dd, H3β) 
5,15 (dd, H2) 
3JH3α-H2 = 9, 
2JH3α- H3β = 15 
3JH3β-H2 = 6  
 
15c H Thienyl p-Tolyl 45 125 2.99 (dd, H3α) 
3.26 (dd, H3β) 
5,51 (dd, H2) 
3JH3α-H2 = 9, 
2JH3α-H3β = 13.2 
3JH3β-H2 = 4.2 
 
15d H Thienyl Phenyl 52 133-134 3.06 (dd, H3α) 
3.32 (dd, H3β) 
5.55 (dd, H2) 
3JH3α-H2 = 9, 
2JH3α- H3β = 12 
3JH3β-H2 = 6 
 
15e H o-Chlorophenyl Phenyl 75 150-151 3.12-3.28 (m, H3)  
5.79-5.83 (m, H2) 
 
15f CH3 o-Chlorophenyl Phenyl 65 122-123 2.99-3.13 (m, H3),  
5.60-5.63 (m, H2) 
 
15g H 2-Chloro-5-nitrophenyl Phenyl 71 167-168 3.16 (d, H3) 
5.74-5.79 (m, H2) 
J = 6 
15h CH3 2-Chloro-5-nitrophenyl Phenyl 77 223-224 3.13 (d, H3) 
5.70-5.67 (m, H2) 
J = 6 
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Table 3: Crystal data of compound 15b. 
 
C22H20N2O2 
Mr = 344.41 
Monoclinic, C2=c 
a = 27.5064 (5) Å 
b = 7.3811 (2) Å 
c = 19.5038 (4) Å 
β = 117.699 (2) 
V = 3506.02 (15) Å3 
Z = 8 
Mo Kα  radiation 
µ = 0.08 mm-1 
 
T = 223 K 
0.30 × 0.20 × 0.15 mm 
Data collection 
Nonius Kappa CCD diffractometer 
19187 measured reflections 
2507 independent reflections 
2836  reflections with I > 3σ(I) 
Rint = 0.06 
Refinement 
R[F2 > 2σ(F2)] = 0.055 
wR(F2) = 0.065 
S = 1.04 
2507 reflections 
235 parameters 
H-atom parameters constrained 
∆ρmax = 0.25 e Å-3 
































































































































































Through this work, we have shown the 
synthesis of substituted benzimidazoles by an 
original method via regression (Ring 
Contraction Rearrangement) of 1H-1,5-
benzodiazepine under basic conditions. 
Structure elucidation of benzodiazepine and 
benzimidazole was made possible by NMR 
and mass spectrometry methods. We have also 
confirmed the benzodiazepine structure by 
realizing X-ray crystal structure analysis.  
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